[
  {
    "objectID": "about.html",
    "href": "about.html",
    "title": "About",
    "section": "",
    "text": "About this site"
  },
  {
    "objectID": "index.html",
    "href": "index.html",
    "title": "J.R. Pradines",
    "section": "",
    "text": "Data scientist, with taste for statistics and mathematics."
  },
  {
    "objectID": "index.html#interests",
    "href": "index.html#interests",
    "title": "J.R. Pradines",
    "section": "Interests",
    "text": "Interests\n\nLink Text\n[1]"
  },
  {
    "objectID": "publications.html",
    "href": "publications.html",
    "title": "Publications",
    "section": "",
    "text": "[1] L. Finnigan et al., “Efficacy and tolerability of AXA1125 (endogenous metabolic modulator) in fatigue-predominant long COVID,” eClinicalMedicine, vol. 2023, no. 1011946, 2023, doi: 10.1016/j.eclinm.2023.101946.\n\n\n[2] J. Pradines and E. Kurtagic, “Methods for treating disorders associated with fibrosis and systemic sclerosis.” Patent. Available: https://patents.google.com/patent/WO2017201491A1\n\n\n[3] V. Farutin et al., “Multiomic study of skin/peripheral blood cell transcriptome and serum proteins in systemic sclerosis,” Arthritis Research & Therapy, vol. 23, no. 1, 2021, Available: http://www.ncbi.nlm.nih.gov/pubmed/34654463\n\n\n[4] J. Pradines et al., “Enhancing reproducibility of gene-expression analysis with known protein functional relationships: The concept of well-associated protein,” PLOS Computational Biology, vol. 16, no. 2, p. e1007684, 2020, Available: https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1007684\n\n\n[5] E. Kurtagic, J. Pradines, A. Manning, and I. Capila, “Application of a novel computational approach to identify new targets and pathways for therapeutic intervention in scleroderma,” Arthritis & Rheumatology, vol. 69, no. suppl 10, 2017, Available: https://acrabstracts.org/abstract/application-of-a-novel-computational-approach-to-identify-new-targets-and-pathways-for-therapeutic-intervention-in-scleroderma/\n\n\n[6] E. Kurtagic et al., “New targets and pathways to treat unmet medical need in scleroderma and fibrotic diseases,” Presentation at PEGS 2017, Boston, 2017, Available: https://www.pegsummit.com/uploadedFiles/PEGS/Agenda/17/2017-PEGS-Brochure.pdf\n\n\n[7] J. Pradines et al., “Combining measurements to estimate properties and characterization extent of complex biochemical mixtures; applications to heparan sulfate,” Scientific Reports, vol. 6, no. 24829, p. srep24829, 2016, Available: http://www.nature.com/articles/srep24829\n\n\n[8] J. Pradines, “Mathematical details of sci.rep. paper,” Scientific Reports (Supplementary), 2016, Available: https://static-content.springer.com/esm/art%3A10.1038%2Fsrep24829/MediaObjects/41598_2016_BFsrep24829_MOESM1_ESM.pdf\n\n\n[9] O. Sobolev et al., “Adjuvanted influenza-H1N1 vaccination reveals lymphoid signatures of age-dependent early responses and of clinical adverse events,” Nature Immunology, vol. 17, no. 2, pp. 204–13, 2016, Available: http://www.ncbi.nlm.nih.gov/pubmed/26726811\n\n\n[10] D. Beccati et al., “An integrated approach using orthogonal analytical techniques to characterize heparan sulfate structure,” Glycoconjugate Journal, 2016, Available: http://link.springer.com/article/10.1007%2Fs10719-016-9734-7\n\n\n[11] J. Anderson et al., “Demonstration of equivalence of a generic glatiramer acetate (glatopa),” Journal of the Neurological Sciences, vol. 359, no. 1–2, pp. 24–34, 2015, Available: http://www.sciencedirect.com/science/article/pii/S0022510X15024740\n\n\n[12] J. D’Alessandro et al., “Equivalent gene expression profiles between glatopa and copaxone,” PLoS One, vol. 10, no. 10, p. e0140299, 2015, Available: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608686/\n\n\n[13] J. Pradines, V. Dancik, A. Ruttenberg, and V. Farutin, “Connectedness profiles in protein networks for the analysis of gene expression data,” RECOMB-2007, 2007, Available: http://link.springer.com/chapter/10.1007%2F978-3-540-71681-5_21\n\n\n[14] V. Farutin et al., “Edge-count probabilities for the identification of local protein communities and their organization,” Proteins: Structure, Function and Bioinformatics, vol. 62, no. 3, pp. 800–18, 2006, Available: http://www.ncbi.nlm.nih.gov/pubmed/16372355\n\n\n[15] J. Pradines, V. Farutin, S. Rowley, and V. Dancik, “Analyzing protein lists with large networks: Edge-count probabilities in random graphs with given expected degrees,” Journal of Computational Biology, vol. 12, no. 2, pp. 113–128., 2005, doi: 10.1089/cmb.2005.12.113.\n\n\n[16] J. Pradines et al., “Detection of activity centers in cellular pathways using transcript profiling,” Journal of Biopharmaceutical Statistics, vol. 14, no. 3, pp. 701–21, 2004, Available: http://www.ncbi.nlm.nih.gov/pubmed/15468760\n\n\n[17] “BIO-IT-world best practices award for the creation of the pathway resource & information system (PARIS) of millennium pharmaceuticals.” 2003. Available: https://www.bio-itworld.com/archive/081804/odyssey.html\n\n\n[18] D. Ficenec et al., “Computational knowledge integration in biopharmaceutical research,” Briefings in Bioinformatics, vol. 4, no. 3, pp. 260–278, 2003, Available: http://bib.oxfordjournals.org/content/4/3/260.long\n\n\n[19] J. Pradines, J. Hasty, and K. Pakdaman, “Complex ligand-protein systems: A globally convergent iterative method for the n x m case,” Journal of Mathematical Biology, vol. 43, no. 4, pp. 313–24, 2001, Available: http://www.ncbi.nlm.nih.gov/pubmed/12120871\n\n\n[20] J. Hasty, J. Pradines, M. Dolnik, and J. Collins, “Noise-based switches and amplifiers for gene expression,” Proceedings of the National Academy of Sciences, vol. 97, no. 5, pp. 2075–80, 2000, Available: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC15756/\n\n\n[21] J. Pradines, G. Osipov, and J. Collins, “Coherence resonance in excitable and oscillatory systems: The essential role of slow and fast dynamics,” Physical Review E, vol. 60, no. 6 Pt A, pp. 6407–10, 1999, Available: http://www.ncbi.nlm.nih.gov/pubmed/11970555\n\n\n[22] J. Pham, K. Pakdaman, and J.-F. Vibert, “Noise-induced coherent oscillations in randomly connected neural networks,” Physical Review E, vol. 58, no. 3, pp. 3610–3622, 1998, Available: http://journals.aps.org/pre/abstract/10.1103/PhysRevE.58.3610\n\n\n[23] J. Pham, J. Champagnat, K. Pakdaman, and J. Vibert, “Activity in sparsely connected excitatory neural networks: Effect of connectivity,” Neural Networks, vol. 11, no. 3, pp. 415–34, 1998, Available: https://www.sciencedirect.com/science/article/abs/pii/S0893608097001536\n\n\n[24] J.-F. Vibert, F. Alvarez, and J. Pham, “Effects of transmission delays and noise in recurrent excitatory neural networks,” Biosystems, vol. 48, no. 1–3, pp. 255–62, 1998, Available: http://www.ncbi.nlm.nih.gov/pubmed/9886655\n\n\n[25] J. Pham, K. Pakdaman, and J.-F. Vibert, “A discrete map for the dynamics of recurrent excitatory neural networks in the presence of noise,” Biosystems, vol. 48, no. 1–3, pp. 179–86, 1998, Available: http://www.ncbi.nlm.nih.gov/pubmed/9886646"
  }
]